Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101 at the European Hematology Association (EHA)
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101…
News
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101 at the European Hematology Association (EHA)
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101…
Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress
Data Will Also Be Presented in a Poster Session at the American Society of Clinical…
Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress
Data Will Also Be Presented in a Poster Session at the American Society of Clinical…
Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2023 European Hematology Association Congress
Updated Clinical Data from the Ongoing Phase 1b Dose-Escalation Study of RVU120 in Patients with AML…
Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2023 European Hematology Association Congress
Updated Clinical Data from the Ongoing Phase 1b Dose-Escalation Study of RVU120 in Patients with AML…
Mendus announces two upcoming presentations at the EHA2023 Hybrid Congress
MENDUS TO PRESENT UPDATES ON IMMUNOMONITORING DATA FROM ADVANCE II TRIAL AND PROGRESS ON THE…
Mendus announces two upcoming presentations at the EHA2023 Hybrid Congress
MENDUS TO PRESENT UPDATES ON IMMUNOMONITORING DATA FROM ADVANCE II TRIAL AND PROGRESS ON THE…
Editas Medicine to Present Clinical Data from the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease at the EHA 2023 Congress
Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
Editas Medicine to Present Clinical Data from the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease at the EHA 2023 Congress
Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
WATERTOWN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
WATERTOWN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
TOWER ONE WIRELESS ANNOUNCES ELEVEN TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 1,200,000
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF APRIL 2023 VANCOUVER, BC, CANADA, May 11,…
TOWER ONE WIRELESS ANNOUNCES ELEVEN TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 1,200,000
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF APRIL 2023 VANCOUVER, BC, CANADA, May 11,…
Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association
A post-hoc subgroup analysis from the AFM13 REDIRECT study in patients with relapsed/refractory (r/r) peripheral…
Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association
A post-hoc subgroup analysis from the AFM13 REDIRECT study in patients with relapsed/refractory (r/r) peripheral…
Agios to Present Clinical and Translational Data at European Hematology Association Annual Congress
– Agios to Present New Analyses from ACTIVATE, ACTIVATE-T and Long-Term Extension Studies in Adults…
Agios to Present Clinical and Translational Data at European Hematology Association Annual Congress
– Agios to Present New Analyses from ACTIVATE, ACTIVATE-T and Long-Term Extension Studies in Adults…